Skip to main content

Three lessons learned from the past year

It’s been a year: a year since the first lockdowns and a year since the landscape of healthcare in the U.S. changed forever. While we’re still evaluating the impacts of the pandemic on healthcare policy, we now have seen enough data to assess the effect of the past year on alternative payments models and how participants are reacting.

It’s been reassuring to see the strength of APMs has broadly held steady, as has the resolve of the participants in those programs, despite the impact of the COVID-19 pandemic. Here’s what we’ve learned this year, along with what (we think) those lessons can teach us about the future.

  1. COVID-19 has not stopped the progress of APMs — but it is delaying it. COVID-19 has extended the period of some programs, like the Comprehensive Care for Joint Replacement and Oncology Care Model, and delayed the start of others, like Kidney Care First and the Radiation Oncology Model. This is, in part, a function of an overwhelmed system. As policymakers and healthcare organizations respond to the pandemic, additional program flexibility has been necessary. This has given providers the chance to evaluate the sustainability of their participation in programs they’re already in, and, while dealing with constrained resources and personnel, deciding if the time is right to enter into new programs.
  2. Most participants are sticking with APMs, despite the pandemic. While the policies stemming from the public health emergency introduced uncertainty into value-based programs, for the most part the pandemic has not scared many participants away. Rather, it is helping them learn what their tolerance for risk is in light of a major situation beyond their control. If anything, APM participants may have been better prepared for the challenge as a result of the value-based transformation they’ve already undertaken. Many participants have approached that transformation seriously and have spent the last couple of years thinking creatively about the ways they can improve care delivery. They have invested a lot of time, energy and money into transformation. Various programs had telehealth waivers in place before the pandemic, so when office visits and care shifted to a virtual format last year, those participants already had some experience to handle the shift. In instances where we saw tremendous declines in participation going into 2021, like in Bundled Payments for Care Improvement Advanced, there were other extenuating changes introduced to the program by CMS that tipped the scales unfavorably toward too much financial risk.
  3. Forecasting risk moving forward could be a challenge. Forecasting performance may not have been easy before 2020, but it was easier to rely on trends from past years to make predictions on cost, improvement and risk. That’s going to be very different moving forward — and not just because 2020 data will be skewed. Moving forward, many patients who deferred care in 2020 for various reasons will re-engage with the healthcare market. Mental and behavioral health challenges are likely to become more important for managing patients’ overall health. That all points toward a high likelihood that the post-COVID era won’t just be picking up where 2019 left off, but will be the start of new trends and require new baselines.

What’s become clear is that while there are many changes, there will, at some point, be a return to the status quo. But that may be a while and it won’t be the status quo of the past. APM participants and any organizations interested in taking on risk or participating in value-based programs in the future should take as many lessons as they can from this past year to become even stronger in the years to come.

Reach out to DataGen to learn more about how to position yourself for success in the new healthcare landscape.

Comments

Popular posts from this blog

Alternative payment models: Strategies for success

In this edition of DataGen Insights, we look at how alternative payment model participants can ensure their processes and workflows are optimally set up for success. To help, DataGen listed the top three strategies all providers participating in APMs can employ and created a handy checklist to enable maximum returns and reduce financial risk. Please explore our website to learn more about our  products and services .  Download DataGen Insights today .  We hope you enjoy!

Why it's critical for Primary Care First participants to control and understand leakage

Patients' primary care visits outside of their attributed primary care office, also called “leaked” patient visits, can have unintended consequences for Primary Care First participants. Beginning July 2022, PCF Cohort 1 will face a reduction in population-based payments based on their leakage rate. The payment adjustment will be based on their 2021 claims data and will roll forward quarterly. To calculate your leakage rate, divide the number of qualifying visits and services your attributed beneficiaries have made to care centers outside of your practice (for example, visits to urgent care centers) by the total number of qualifying visits and services your attributed beneficiaries have made. Calculating primary care leakage with claims data alone comes with some unintended challenges. Unfortunately, some circumstances can unfairly and negatively impact a practice’s leakage rate: Nuances classifying care delivered by provider team members: It’s difficult to distinguish

CMMI’s New Enhancing Oncology Model – Deadline Approaching

As the final at-risk period for the Oncology Care Model was closing at the end of June, the Center for Medicare and Medicaid Innovation announced its new Enhancing Oncology Model (EOM). EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment.  What is EOM? EOM is a voluntary, five-year model set to begin July 1, 2023. Patients undergoing chemotherapy for the treatment of cancer will trigger six-month episodes of care.  Eligible EOM participants include physician group practices with at least one Medicare-enrolled physician or a non-physician practitioner who furnishes evaluation and management services to Medicare beneficiaries receiving chemotherapy for cancer treatment.  EOM participants are required to implement eight participant redesign activities to drive care transformation in their practice. Examples include the provision of patient navigation, 24/7 access to an appropriate c